Damià Tormo Carulla, 2017 Princess of Girona Foundation Business Award

The winner was chosen for combining a brilliant scientific career with being an entrepreneur and investor capable of connecting the world of research with successful entrepreneurial initiative in Spain.

Damià Tormo Carulla (Valencia, 1981) graduated in biology from the University of Valencia and FHS Bonn-Rhein-Sieg (Germany) and holds a doctorate in immunology and molecular genetics from Rheinische Friedrich-Wilhelms-Universität Bonn (Germany). Damià also has an international master’s in biotechnological management (MBM) from IE Business School and has spent time as a student and researcher at institutions such as the University of Cambridge (UK), Michigan University (USA) and the Spanish National Cancer Research Centre (CNIO). Currently, Damià is the founder and managing partner of Fondo Columbus Venture Partners and founder and CEO of different biotechnology companies that are developing drugs, software, biotechnology services and cosmetics. Damià is also the founder and CEO of Artax Biopharma, an American company that develops drugs to treat autoimmune diseases. Previously, he was the founder and CEO until 2013 (now he is the president) of BiOncoTech Therapeutics (Spain) which develops drugs to treat aggressive tumours. 

The award, which last year went to businessman and co-founder of Carto, Sergio Álvarez Leiva, for his ability to represent data using cartography, recognises the careers of young people with entrepreneurial initiative who have led or are promoting original and viable business projects

 

Copyright © 2017 Princess of Girona Foundation
C. Juli Garreta, 1, 1r E   17002 Girona   (Spain)
Tel. 34 972 410 410   Fax 34 972 410 400   info@fpdgi.org

  • Casa Real
  • Fundació Príncep de Girona
Interactiu